Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Adults - 18 - 64
  • California
  • Los Angeles


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com




Results

Post your clinical trial on JoinClinicalTrials.com
Hot

Post your clinical trial on JoinClinicalTrials.com


Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

Results 1 - 1 of 1
  • <<
  • <
  • 1
  • >
  • >>

  • Mindfulness for at Risk Youth: Understanding Substance Use and Important Mechanisms of Change
    NCT04160754
    Conditions:   Alcohol Use, Underage;   Alcohol Problem Drinking;   Substance Use
    Interventions:   Behavioral: Mindfulness Based Relapse Prevention;   Behavioral: Control (CTL)
    Sponsor:   University of Southern California
    Recruiting
  • Advancing Postmenopausal Preventive Therapy
    NCT04103476
    Conditions:   Atherosclerosis;   Cognitive Decline
    Interventions:   Combination Product: Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg;   Other: Placebo
    Sponsors:   University of Southern California;   National Institute on Aging (NIA)
    Recruiting
  • Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)
    NCT04023487
    Condition:   Diabetes Mellitus, Type 1
    Intervention:   Behavioral: Resilient, Empowered, Active Living-Telehealth (REAL-T)
    Sponsors:   University of Southern California;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting
  • Smoking and Ventricular Repolarization
    NCT03916341
    Conditions:   Sudden Cardiac Death;   Prolonged QTc Interval
    Interventions:   Other: EC with nicotine;   Other: EC without nicotine;   Other: control;   Other: TC with nicotine (own brand);   Other: research TC with very low level nicotine
    Sponsors:   University of California, Los Angeles;   Tobacco Related Disease Research Program
    Recruiting
  • Effects of Inflammation on Affect and Behavior
    NCT03848715
    Conditions:   Anhedonia;   Depression
    Interventions:   Biological: Endotoxin;   Biological: Placebo
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Transcranial Direct Current Stimulation in Major Depression
    NCT03556124
    Condition:   Major Depressive Disorder
    Interventions:   Device: Active - HD tDCS;   Device: Sham - HD tDCS;   Device: Active - Conventional tDCS;   Device: Sham - Conventional tDCS
    Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH)
    Recruiting
  • Ibudilast and Withdrawal-Related Dysphoria
    NCT03489850
    Condition:   Alcohol Use Disorder
    Interventions:   Drug: Ibudilast;   Other: Placebo
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
    NCT02823041
    Conditions:   Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder
    Interventions:   Behavioral: Cognitive Training;   Behavioral: Aerobic Exercise;   Behavioral: Case management and supportive psychotherapy;   Behavioral: Individual Placement and Support
    Sponsor:   University of California, Los Angeles
    Recruiting
  • PEERS© for Careers
    NCT04114942
    Condition:   Autism Spectrum Disorder
    Interventions:   Behavioral: Never Coach;   Behavioral: Internship Only Coach;   Behavioral: Didactic Only Coach;   Behavioral: Constant Coach
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Affective Management Training for Cannabis Misuse
    NCT03432013
    Condition:   Cannabis Use Disorder
    Interventions:   Behavioral: CUD-AMT;   Behavioral: SUD-CBT
    Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
    NCT01889199
    Condition:   Polycystic Ovary Syndrome (PCOS)
    Interventions:   Drug: Flutamide;   Other: Placebo
    Sponsors:   University of California, Los Angeles;   Oregon Health and Science University
    Recruiting
  • Socially Assistive Robots to Enhance Magnification Device Use for Reading
    NCT04190134
    Condition:   Low Vision
    Intervention:   Behavioral: Socially Assistive Robot for Low Vision Rehabilitation
    Sponsors:   University of California, Los Angeles;   University of Southern California
    Recruiting
  • A Mind-Body Intervention for Chemotherapy-Induced Peripheral Neuropathy
    NCT04185610
    Conditions:   Chemotherapy-induced Peripheral Neuropathy;   Cancer
    Intervention:   Other: Qi Gong
    Sponsor:   Arash Asher, MD
    Recruiting
  • Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted
    NCT04185311
    Conditions:   Anatomic Stage 0 Breast Cancer AJCC v8;   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   HER2/Neu Negative;   Invasive Ductal Carcinoma, Not Otherwise Specified;   Progesterone Receptor Negative;   Prognostic Stage 0 Breast Cancer AJCC v8;   Prognostic Stage I Breast Cancer AJCC v8;   Prognostic Stage IA Breast Cancer AJCC v8;   Prognostic Stage IB Breast Cancer AJCC v8;   Prognostic Stage II Breast Cancer AJCC v8;   Prognostic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Triple-Negative Breast Carcinoma
    Interventions:   Biological: Ipilimumab;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)
    NCT04171050
    Condition:   Pain Management
    Interventions:   Drug: Local anaesthetic;   Drug: Pudendal Nerve Block plus anesthesia
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Mindfulness Meditation and Bariatric Surgery
    NCT04167852
    Conditions:   Opioid Use;   Bariatric Surgery Candidate;   Pain, Postoperative
    Interventions:   Behavioral: Daily text message;   Behavioral: Mindfulness intervention
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
    NCT04167085
    Condition:   Epistaxis
    Interventions:   Drug: Doxycycline;   Other: Placebo
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
    NCT04165694
    Conditions:   Bariatric Surgery Candidate;   Severe Obesity
    Intervention:   Procedure: Single Anastomosis Duodenal Ileal Bypass (SADI)
    Sponsor:   Kaiser Permanente
    Recruiting
  • Study With Lu AF87908 in Healthy Subjects and Patients With Alzheimer's Disease
    NCT04149860
    Conditions:   Healthy;   Alzheimer Disease
    Interventions:   Drug: Lu AF87908;   Drug: Placebo
    Sponsor:   H. Lundbeck A/S
    Recruiting
  • Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation
    NCT04075890
    Conditions:   OCD;   Decision-Making;   tDCS;   fMRI
    Intervention:   Device: transcranial Direct Current Stimulation (tDCS)
    Sponsor:   University of California, Los Angeles
    Recruiting
  • OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
    NCT04069923
    Condition:   Health Status Unknown
    Intervention:   Other: Magnesium-based Bone Void Filler
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy
    NCT04061577
    Condition:   Acute Ischemic Stroke
    Intervention:   Device: Transcranial Direct Current Stimulation (tDCS)
    Sponsors:   University of California, Los Angeles;   The City College of New York
    Recruiting
  • 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
    NCT04050215
    Conditions:   Biochemically Recurrent Prostate Carcinoma;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Prostate Carcinoma;   PSA Level Greater Than Fifty;   PSA Progression;   Stage IV Prostate Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8
    Interventions:   Procedure: Computed Tomography;   Drug: Gallium Ga 68-labeled PSMA-11;   Procedure: Positron Emission Tomography;   Other: Questionnaire Administration
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Optimizing Exposure Therapy for Anxiety Disorders
    NCT04048824
    Conditions:   Social Anxiety Disorder;   Panic Disorder
    Interventions:   Behavioral: Inhibitory Learning-Based Exposure;   Behavioral: Habituation-Based Exposure
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Developing Dynamic Theories for Behavior Change
    NCT04043650
    Condition:   Physical Activity
    Intervention:   Behavioral: HeartSteps
    Sponsors:   University of Southern California;   University of California, San Diego;   Arizona State University;   Kaiser Permanente;   Northeastern University;   University of Massachusetts, Amherst
    Recruiting
  • SMS Education for Post-operative Pain
    NCT04039191
    Conditions:   Opioid Use;   Pain, Postoperative
    Interventions:   Behavioral: SMS education;   Behavioral: SMS survey
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • TMS and Exposure Therapy
    NCT04019054
    Conditions:   Arachnophobia;   Phobia
    Interventions:   Device: Intermittent Theta Burst Stimulation (iTBS), Ventromedial Prefrontal Cortex (vmPFC);   Device: Intermittent Theta Burst Stimulation (iTBS), vertex
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
    NCT04007029
    Conditions:   CD19 Positive;   CD20 Positive;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Diffuse Large B-Cell Lymphoma;   Refractory Follicular Lymphoma;   Refractory Mantle Cell Lymphoma;   Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;   Refractory Small Lymphocytic Lymphoma
    Interventions:   Biological: Chimeric Antigen Receptor T-Cell Therapy;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Biological: Tocilizumab
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI);   Parker Institute for Cancer Immunotherapy
    Recruiting
  • Virtual Reality in SOD
    NCT03999333
    Condition:   Sphincter of Oddi Dysfunction
    Intervention:   Device: Virtual Reality (Oculus Go)
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • SPECT/CT for the Characterization of Renal Masses
    NCT03996850
    Conditions:   Kidney Neoplasm;   Renal Mass
    Interventions:   Procedure: Computed Tomography;   Other: Questionnaire Administration;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Sestamibi
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Nivolumab in Combination With Chemotherapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
    NCT03970252
    Conditions:   Borderline Resectable Pancreatic Adenocarcinoma;   Resectable Pancreatic Ductal Adenocarcinoma
    Interventions:   Drug: Fluorouracil;   Drug: Irinotecan;   Drug: Irinotecan Hydrochloride;   Drug: Leucovorin;   Drug: Leucovorin Calcium;   Biological: Nivolumab;   Drug: Oxaliplatin;   Procedure: Therapeutic Conventional Surgery
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Quadratus Lumborum Nerve Blocks for Myomectomies
    NCT03935815
    Conditions:   Laparoscopic Myomectomy;   Quadratus Lumborum Nerve Block
    Interventions:   Drug: Ropivacaine injection;   Procedure: Sham treatment
    Sponsor:   University of California, Los Angeles
    Recruiting
  • The Getting Off App for Methamphetamine-Using Gay and Bisexual Men
    NCT03884946
    Conditions:   Methamphetamine Abuse;   HIV/AIDS
    Intervention:   Other: Getting Off App
    Sponsors:   Friends Research Institute, Inc.;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Train Your Brain: Neurofeedback Intervention for PTSD
    NCT03858933
    Condition:   Stress Disorders, Post-Traumatic
    Intervention:   Device: eBrainFit Platform
    Sponsors:   University of Southern California;   Tel Aviv University
    Recruiting
  • Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
    NCT03844412
    Conditions:   Vestibulodynia;   Temporomandibular Disorder;   Fibromyalgia Syndrome;   Irritable Bowel Syndrome;   Migraines;   Tension Headache;   Endometriosis;   Interstitial Cystitis;   Back Pain;   Chronic Fatigue Syndrome
    Interventions:   Drug: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream;   Drug: Nortriptyline;   Drug: Placebo cream;   Drug: Placebo pill
    Sponsors:   Duke University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting
  • WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
    NCT03824652
    Condition:   Prostate Cancer
    Interventions:   Other: walnuts;   Other: usual diet;   Other: phone counseling with dietitian
    Sponsors:   Stephen Freedland;   California Walnut Commission
    Recruiting
  • LOL: It's All Improv After Cancer!™
    NCT03824132
    Conditions:   Breast Cancer;   Psychological Distress
    Interventions:   Behavioral: Improvisational comedy classes;   Behavioral: Waitlist control
    Sponsors:   Arash Asher, MD;   Tower Cancer Research Foundation
    Recruiting
  • Reactive vs. Proactive Pain Control in IBD
    NCT03798405
    Conditions:   Inflammatory Bowel Diseases;   Pain;   Opioid Use;   Crohn Disease;   Ulcerative Colitis
    Intervention:   Behavioral: Proactive Analgesic Inpatient Narcotic-Sparing
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
    NCT03784898
    Condition:   Multiple Sclerosis
    Intervention:   Other: Blood draw for future biomarker analysis
    Sponsor:   Genzyme, a Sanofi Company
    Recruiting
  • Ketogenic Diet in Non-alcoholic Fatty Liver Disease
    NCT03784716
    Conditions:   Fatty Liver, Nonalcoholic;   Liver Diseases
    Interventions:   Other: Ketogenic Diet;   Other: Standard Weight Loss Diet
    Sponsor:   Shehnaz Hussain
    Recruiting
  • Key Dimensions of PTSD and ED
    NCT03778307
    Conditions:   Trauma;   PTSD;   Endothelial Dysfunction
    Interventions:   Behavioral: Psychophysiological fear conditioning and extinction task;   Behavioral: Eyetracking task
    Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting
  • Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease
    NCT03775096
    Conditions:   REM Sleep Behavior Disorder;   Pre-motor Parkinson Disease;   Symptomatic Parkinson Disease
    Intervention:   Drug: Carvedilol
    Sponsor:   Michele Tagliati, MD
    Recruiting
  • Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
    NCT03774446
    Condition:   Cushing Disease
    Intervention:   Drug: Seliciclib
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Efficacy and Safety of SYN-010 in IBS-C
    NCT03763175
    Condition:   Irritable Bowel Syndrome With Constipation
    Interventions:   Drug: SYN-010 21 mg;   Drug: SYN-010 42 mg;   Drug: Placebo
    Sponsors:   Cedars-Sinai Medical Center;   Synthetic Biologics Inc.
    Recruiting
  • Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab
    NCT03747120
    Conditions:   HER2-positive Breast Cancer;   Breast Cancer
    Interventions:   Drug: Paclitaxel;   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Pembrolizumab
    Sponsors:   Cedars-Sinai Medical Center;   Merck Sharp & Dohme Corp.
    Recruiting
  • Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery
    NCT03738904
    Condition:   Anorectal Disorder
    Interventions:   Combination Product: ERAS;   Combination Product: Standard of care
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke
    NCT03737786
    Condition:   Acute Stroke
    Intervention:   Other: Tight control of end-tidal CO2 levels
    Sponsors:   University of California, Los Angeles;   University of Southern California
    Recruiting
  • Social Engagement Strategies to Improve Medication Adherence
    NCT03734887
    Conditions:   Diabetes;   Atherosclerosis Cardiovascular Disease;   Congestive Heart Failure;   Poor Medication Adherence
    Interventions:   Behavioral: Social Network Feedback;   Behavioral: Private Feedback
    Sponsor:   University of California, Los Angeles
    Recruiting
  • PK/PD of Vitamin D3 in Adults With CF
    NCT03734744
    Conditions:   Vitamin D Deficiency;   Cystic Fibrosis
    Intervention:   Dietary Supplement: Vitamin D3
    Sponsor:   University of Southern California
    Recruiting
  • 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent Glioblastoma
    NCT03732352
    Conditions:   EGFR Gene Amplification;   EGFR Gene Mutation;   Glioblastoma;   Recurrent Glioblastoma;   Supratentorial Glioblastoma;   TP53 wt Allele
    Interventions:   Other: Fludeoxyglucose F-18;   Drug: Osimertinib;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI);   Translational Research in Oncology;   AstraZeneca
    Recruiting
  • Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
    NCT03711292
    Conditions:   Antimicrobial Stewardship;   Acute Bronchitis;   Upper Respiratory Infection
    Intervention:   Behavioral: Antibiotic Stewardship
    Sponsors:   Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;   Los Angeles County Department of Public Health;   University of California, Los Angeles
    Recruiting
  • Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
    NCT03707262
    Conditions:   Renal Transplant Rejection;   Tolerance;   Kidney Transplant
    Intervention:   Biological: Donor CD34+ and CD3+ cells
    Sponsors:   Jeffrey Veale, MD;   OneLegacy Foundation
    Recruiting
  • The Safety and Intake Rate of a Natural Compound Arctigenin in Healthy Men
    NCT03703388
    Condition:   Healthy
    Intervention:   Dietary Supplement: Arctigenin
    Sponsors:   University of California, Los Angeles;   Charles Drew University of Medicine and Science
    Recruiting
  • The IBD&me Randomized Controlled Trial
    NCT03695783
    Condition:   Inflammatory Bowel Diseases
    Interventions:   Other: Online decision aid called IBD&me;   Other: Standardized educational material
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
    NCT03672773
    Conditions:   Recurrent Extensive Stage Small Cell Lung Carcinoma;   Refractory Extensive Stage Small Cell Lung Carcinoma
    Interventions:   Drug: Talazoparib;   Drug: Temozolomide
    Sponsors:   Jonsson Comprehensive Cancer Center;   Translational Research in Oncology;   National Cancer Institute (NCI)
    Recruiting
  • Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner
    NCT03618134
    Conditions:   Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8;   Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Human Papillomavirus Positive;   Oropharyngeal Squamous Cell Carcinoma;   p16 Positive Neoplastic Cells Present;   Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8;   Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    Interventions:   Biological: Durvalumab;   Procedure: Modified Radical Neck Dissection;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Transoral Robotic Surgery;   Biological: Tremelimumab
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • DHA Brain Delivery Trial
    NCT03613844
    Condition:   Brain DHA Delivery and Alzheimer's Disease Risk
    Interventions:   Drug: DHA;   Drug: Placebo
    Sponsors:   University of Southern California;   Huntington Medical Research Institutes;   National Institute on Aging (NIA);   Alzheimer’s Drug Discovery Foundation
    Recruiting
  • Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
    NCT03608228
    Condition:   Parkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) Surgery
    Intervention:   Other: Measuring electrical signals from the brain
    Sponsors:   University of California, Los Angeles;   The Cleveland Clinic;   University of California, San Francisco;   University of California, San Diego;   California Institute of Technology;   Cedars-Sinai Medical Center
    Recruiting
  • Ibudilast for the Treatment of Alcohol Use Disorder
    NCT03594435
    Condition:   Alcohol Use Disorder
    Interventions:   Drug: Ibudilast;   Drug: Placebo oral capsule
    Sponsors:   University of California, Los Angeles;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   MediciNova
    Recruiting
  • Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]
    NCT03582774
    Condition:   Recurrent Prostate Carcinoma
    Intervention:   Drug: 68Ga-PSMA-11
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
    NCT03574038
    Condition:   Stroke, Acute
    Interventions:   Device: Transcranial Direct Current Stimulation;   Other: Sham Stimulation
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
    NCT03563352
    Conditions:   Breast Carcinoma;   Cholangiocarcinoma;   Colorectal Carcinoma;   Gastric Carcinoma;   Malignant Digestive System Neoplasm;   Pancreatic Carcinoma;   Prostate Carcinoma
    Interventions:   Other: Interview;   Other: Survey Administration
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
    NCT03548584
    Conditions:   Agitaton Associated With Alzheimer's Dementia;   Alzheimer Dementia
    Interventions:   Drug: Brexpiprazole;   Other: Placebo
    Sponsors:   Otsuka Pharmaceutical Development & Commercialization, Inc.;   H. Lundbeck A/S
    Recruiting
  • Peri-Operative Ipilimumab+Nivolumab and Cryoablation Versus Standard Care in Women With Triple-negative Breast Cancer
    NCT03546686
    Condition:   Breast Cancer
    Interventions:   Drug: Ipilimumab;   Drug: Nivolumab;   Procedure: Core Biopsy/Cryoablation;   Procedure: Breast Surgery
    Sponsors:   Cedars-Sinai Medical Center;   Memorial Sloan Kettering Cancer Center
    Recruiting
  • Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC
    NCT03546361
    Condition:   Carcinoma, Non-Small-Cell Lung
    Interventions:   Genetic: Ad-CCL21-DC 1 x 07;   Genetic: Ad-CCL21-DC 3 x 07;   Genetic: Ad-CCL21-DC .05 x 07;   Drug: Pembrolizumab;   Genetic: Ad-CCL21-DC ExD
    Sponsors:   Jonsson Comprehensive Cancer Center;   California Institute for Regenerative Medicine (CIRM);   Merck Sharp & Dohme Corp.;   National Cancer Institute (NCI)
    Recruiting
  • Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
    NCT03541850
    Conditions:   PSA Level Greater Than 0.03;   PSA Progression;   Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7;   Stage II Prostate Adenocarcinoma AJCC v7;   Stage III Prostate Adenocarcinoma AJCC v7
    Interventions:   Drug: Antiandrogen Therapy;   Other: Quality-of-Life Assessment;   Radiation: Stereotactic Body Radiation Therapy
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
    NCT03538691
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Brexpiprazole;   Drug: Placebo;   Drug: Citalopram Hydrobromide;   Drug: Escitalopram;   Drug: Fluoxetine;   Drug: Paroxetine;   Drug: Sertraline;   Drug: Duloxetine;   Drug: Venlafaxine Extended Release Oral Capsule
    Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
    Recruiting
  • Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers
    NCT03538574
    Condition:   Insomnia Chronic
    Interventions:   Behavioral: CBT-I;   Behavioral: MAP-I
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Hiatal Interrogation in Sleeve Gastrectomy
    NCT03527810
    Condition:   Sleeve Gastrectomy
    Interventions:   Procedure: Sleeve Gastrectomy Without Interrogation of Hiatus;   Procedure: Sleeve Gastrectomy With Interrogation of Hiatus
    Sponsors:   Miguel Burch;   Cedars-Sinai Medical Center
    Recruiting
  • Haploidentical Stem Cell Transplant With Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
    NCT03524235
    Conditions:   Multiple Myeloma;   CLL;   Chronic Lymphocytic Leukemia;   Lymphoma;   Hodgkin Lymphoma
    Interventions:   Radiation: Total Body Irradiation;   Procedure: Haploidentical Stem Cell Transplantation;   Biological: CD56-Enriched Donor Lymphocyte Infusion;   Drug: Bendamustine;   Drug: Fludarabine;   Drug: Rituximab
    Sponsors:   Noah Merin;   Miltenyi Biotec GmbH;   Teva Pharmaceutical Industries
    Recruiting
  • Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training
    NCT03503669
    Conditions:   Mild Cognitive Impairment;   Alzheimer's Disease
    Interventions:   Behavioral: Memory Training;   Behavioral: Kundalini yoga and meditation
    Sponsors:   University of California, Los Angeles;   Alzheimer's Research and Prevention Foundation
    Recruiting
  • Rifaximin on Visceral Hypersensitivity
    NCT03462966
    Conditions:   Visceral Hypersensitivity;   Irritable Bowel Syndrome
    Intervention:   Drug: Rifaximin
    Sponsors:   Cedars-Sinai Medical Center;   Bausch Health Americas, Inc.
    Recruiting
  • SMART Program in Irritable Bowel Syndrome (IBS)
    NCT03454386
    Condition:   Irritable Bowel Syndrome
    Interventions:   Behavioral: Stress Management and Resilience Training Program;   Behavioral: Self-Management Stress Reduction Program
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.
    NCT03428490
    Conditions:   Alcohol Use Disorder;   Social Anxiety Disorder
    Interventions:   Behavioral: Fully integrated treatment;   Behavioral: Stand-alone Intensive Outpatient Program
    Sponsors:   University of California, Los Angeles;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Matrix Institute on Addictions
    Recruiting
  • Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
    NCT03425461
    Conditions:   Metastatic Melanoma;   Stage III Cutaneous Melanoma AJCC v7;   Stage IIIA Cutaneous Melanoma AJCC v7;   Stage IIIB Cutaneous Melanoma AJCC v7;   Stage IIIC Cutaneous Melanoma AJCC v7;   Stage IV Cutaneous Melanoma AJCC v6 and v7
    Interventions:   Biological: Anti-SEMA4D Monoclonal Antibody VX15/2503;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Pharmacological Study
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
    NCT03411070
    Conditions:   Positive Axillary Lymph Node;   Stage 0 Breast Cancer AJCC v6 and v7;   Stage I Breast Cancer AJCC v7;   Stage IA Breast Cancer AJCC v7;   Stage IB Breast Cancer AJCC v7;   Stage II Breast Cancer AJCC v6 and v7;   Stage IIA Breast Cancer AJCC v6 and v7;   Stage IIB Breast Cancer AJCC v6 and v7;   Stage III Breast Cancer AJCC v7;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7
    Interventions:   Device: Implanted Medical Device;   Procedure: Therapeutic Conventional Surgery
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy
    NCT03376984
    Conditions:   Dental Pulp Diseases;   Dental Pulp Necrosis;   Nerve Root Pain Nec
    Interventions:   Combination Product: ND and AMOX modified Gutta Percha;   Device: Gutta Percha
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Breast Cancer Study of Preoperative Pembrolizumab + Radiation
    NCT03366844
    Condition:   Breast Cancer
    Interventions:   Drug: Pembrolizumab;   Radiation: RT Boost
    Sponsor:   Stephen Shiao
    Recruiting
  • Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing
    NCT03341559
    Condition:   Diabetic Foot Ulcer
    Intervention:   Device: Spatial Frequency Domain Imaging (SFDI)
    Sponsors:   University of Southern California;   Modulated Imaging Inc.
    Recruiting
  • Sleep and Healthy Aging Research for Depression (SHARE-D) Study
    NCT03256760
    Condition:   Depression in Old Age
    Interventions:   Biological: Endotoxin;   Biological: Placebo
    Sponsor:   Michael Irwin, MD
    Recruiting
  • Target Engagement and Response to Oxytocin
    NCT03245437
    Condition:   Schizophrenia
    Interventions:   Drug: Oxytocin nasal spray;   Behavioral: Social Cognition Skills Training;   Behavioral: Health Management;   Drug: Placebo nasal spray
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Transcutaneous Electrical Acupoint Stimulation (TEAS) for Chronic Constipation
    NCT03243955
    Condition:   Constipation - Functional
    Interventions:   Device: Verum TEAS;   Device: Sham TEAS
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Intra-articular Adipose Tissue Injections for Osteoarthritis
    NCT03242707
    Condition:   Osteoarthritis, Knee
    Interventions:   Biological: Autologous adipose tissue injection;   Drug: Hyaluronic Acid
    Sponsor:   University of Southern California
    Recruiting
  • Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
    NCT03219372
    Conditions:   Hepatocellular Carcinoma;   Liver Cirrhoses
    Interventions:   Drug: Pravastatin Pill;   Drug: Placebo Oral Tablet
    Sponsors:   Cedars-Sinai Medical Center;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting
  • Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
    NCT03207854
    Conditions:   Healthy Subject;   Hematologic and Lymphocytic Disorder;   Hematopoietic and Lymphoid Cell Neoplasm;   Immune System Disorder;   Malignant Neoplasm
    Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Preoperative Alpha Blockade for Pheochromocytoma
    NCT03176693
    Conditions:   Pheochromocytoma;   Paraganglioma
    Interventions:   Drug: Phenoxybenzamine;   Drug: Doxazosin
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
    NCT03163368
    Condition:   Brain Metastases
    Interventions:   Radiation: Neoadjuvant stereotactic radiosurgery;   Procedure: Neurosurgical resection
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute
    NCT03098576
    Condition:   Cancer
    Interventions:   Other: Matched targeted drug treatment;   Other: Unmatched standard of care
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • QSM and Regional DCE MRI Permeability Using GOCART Technique
    NCT03091803
    Condition:   Intracranial Neoplasm
    Interventions:   Device: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Drug: Gadobenate Dimeglumine;   Drug: Gadoterate Meglumine;   Device: Magnetic Resonance Imaging
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Oxandrolone Rotator Cuff Trial
    NCT03091075
    Condition:   Rotator Cuff Tear
    Interventions:   Drug: Oxandrolone Pill;   Drug: Placebo Oral Tablet
    Sponsor:   University of Southern California
    Recruiting
  • Whole-Heart Myocardial Blood Flow Quantification Using MRI
    NCT03064295
    Conditions:   Coronary Artery Disease;   Coronary Microvascular Disease
    Interventions:   Device: Myocardial Perfusion Cardiac MRI.;   Drug: Contrast;   Drug: Pharmacologic Stress Agent
    Sponsors:   Cedars-Sinai Medical Center;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting
  • My Nutritional Health App Testing
    NCT03052452
    Condition:   Gastrointestinal Irritation
    Intervention:   Other: My Nutritional Health App
    Sponsors:   Cedars-Sinai Medical Center;   University of Michigan;   Nestlé
    Recruiting
  • Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
    NCT03042897
    Conditions:   Estrogen Receptor Positive;   Obesity;   Progesterone Receptor Positive;   Stage I Uterine Corpus Cancer;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer
    Interventions:   Dietary Supplement: Dietary Intervention;   Behavioral: Exercise Intervention;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
    NCT02960308
    Conditions:   Head and Neck Neoplasm;   Malignant Head and Neck Neoplasm
    Intervention:   Radiation: Computed Tomography Perfusion Imaging
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy
    NCT02960282
    Conditions:   Metastatic Carcinoma;   Stage IV Colorectal Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer
    Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
    NCT02910180
    Conditions:   Cerebrovascular Diseases;   Ischemic Stroke;   Repository
    Intervention:  
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet
    NCT02881307
    Conditions:   Rheumatoid Arthritis;   Overweight
    Interventions:   Dietary Supplement: Whey Protein&Prebiotic Supplement;   Behavioral: Dietary Counseling;   Behavioral: Dietary recommendations
    Sponsor:   Dr. Veena Ranganath
    Recruiting
  • Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
    NCT02866682
    Condition:   Renal Transplant Rejection
    Interventions:   Drug: Prograf;   Drug: Tacrolimus
    Sponsors:   University of California, Los Angeles;   Food and Drug Administration (FDA)
    Recruiting
  • Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis
    NCT02735746
    Conditions:   Lung Cancer;   Breast Cancer;   Mediastinum Lesion;   Radiation Pneumonitis
    Interventions:   Radiation: 4D Computed Tomography (CT);   Radiation: Cone Beam CT;   Radiation: Low-dose Cinefluorography;   Device: Pulmonary Function Tests
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study
    NCT02726906
    Conditions:   Aging;   Cognitive Ability, General
    Interventions:   Behavioral: Moderate-aerobic walking;   Radiation: Positron Emission Tomography (PET) scan;   Behavioral: Healthy living education;   Device: Physical activity monitor
    Sponsor:   University of Southern California
    Recruiting
  • Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
    NCT02701153
    Condition:   Recurrent Adult Soft Tissue Sarcoma
    Interventions:   Procedure: Conventional Surgery;   Radiation: Hypofractionated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Nanodiamond Modified Gutta Percha (NDGP) Composite for Non-surgical Root Canal Therapy (RCT) Filler Material
    NCT02698163
    Conditions:   Dental Pulp Diseases;   Dental Pulp Necrosis;   Nerve Root Pain Nec
    Interventions:   Device: Nanodiamond reinforced Gutta Percha;   Device: Gutta Percha
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
    NCT02681601
    Condition:   Cancer of Pancreas
    Interventions:   Dietary Supplement: Nutrawell Powder;   Other: Diet Only;   Dietary Supplement: OmegaRich fish oil supplement
    Sponsor:   Jonsson Comprehensive Cancer Center
    Recruiting
  • The Effect of Coffee Consumption in Enhancing Recovery of Bowel Function Following Colorectal Surgery.
    NCT02639728
    Condition:   Postoperative Ileus
    Interventions:   Other: Regular Coffee;   Other: Decaffeinated coffee;   Other: Warm water
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Active Surveillance of Papillary Thyroid Microcarcinoma
    NCT02609685
    Condition:   Papillary Thyroid Microcarcinoma
    Intervention:   Other: Active Surveillance
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Use of Acthar in Rheumatoid Arthritis (RA) Related Flares
    NCT02541955
    Condition:   Rheumatoid Arthritis (RA)
    Intervention:   Drug: Acthar
    Sponsor:   Dr. Veena Ranganath
    Recruiting
  • Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
    NCT02505477
    Conditions:   Schizophrenia;   Cognitive Deficits;   Schizophrenia; Negative Type
    Interventions:   Drug: N-acetylcysteine;   Other: Treatment as Usual
    Sponsor:   University of California, Los Angeles
    Recruiting
  • High-Intensity Interval Training for Stage I-III Breast Cancer Patients
    NCT02454777
    Conditions:   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
    Interventions:   Behavioral: Exercise Intervention;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • FORE-SIGHT Tissue Oximeter During Cardiac Surgery
    NCT02426268
    Condition:   Cardiac Surgical Patients
    Intervention:  
    Sponsors:   University of California, Los Angeles;   CAS Medical Systems, Inc.
    Recruiting
  • A Mobile and Virtual Reality Intervention for Adolescent Depression
    NCT04165681
    Condition:   Depression
    Intervention:   Other: Limbix Spark
    Sponsor:   Limbix Health, Inc.
    Recruiting
  • Spinal Cord Neuromodulation for SCI
    NCT02313194
    Conditions:   Cervical Spinal Cord Injury;   Tetraparesis;   Tetraplegia
    Intervention:   Device: Epidural Stimulation
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
    NCT02253251
    Condition:   Cancer
    Intervention:   Genetic: KRAS-variant and microRNA binding site mutation testing
    Sponsor:   MiraKind
    Recruiting
  • Core Biopsies for Establishing a Breast Tumor Tissue Repository
    NCT02250352
    Condition:   Breast Cancer
    Intervention:   Other: cytology specimen collection procedure
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Stem Cell Gene Therapy for Sickle Cell Disease
    NCT02247843
    Condition:   Sickle Cell Disease
    Intervention:   Biological: βAS3-FB vector transduced peripheral blood CD34+ cells
    Sponsors:   Donald B. Kohn, M.D.;   California Institute for Regenerative Medicine (CIRM)
    Recruiting
  • Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis
    NCT03985020
    Condition:   Non-Alcoholic Fatty Liver Disease
    Interventions:   Other: Stevia Intervention;   Other: Water Intervention
    Sponsor:   Children's Hospital Los Angeles
    Recruiting
  • Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
    NCT02176902
    Conditions:   Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
    Interventions:   Behavioral: behavioral dietary intervention;   Dietary Supplement: omega-3 fatty acid;   Other: laboratory biomarker analysis
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • 3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
    NCT02163408
    Condition:   Carotid Artery Disease
    Intervention:   Other: MRI with/without contrast
    Sponsors:   Cedars-Sinai Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   American Heart Association
    Recruiting
  • Empiric Treatment for Acute HIV in the ED
    NCT03711253
    Condition:   Acute HIV Infection
    Intervention:   Drug: Bictegravir 50mg+Tenofovir AF 25 mg+emtricitabine 200 mg
    Sponsor:   University of Southern California
    Recruiting
  • Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV
    NCT03702049
    Condition:   Latent Tuberculosis Infection
    Intervention:   Behavioral: Nurse-led Community Health Worker TBI (RN/CHW TBI) program
    Sponsors:   University of California, Irvine;   University of California, Los Angeles
    Recruiting
  • Deep Brain Stimulation of the Amygdala for Combat Post-Traumatic Stress Disorder
    NCT02091843
    Condition:   Posttraumatic Stress Disorder
    Interventions:   Procedure: DBS of the Basolateral Nucleus of the Amygdala;   Device: Medtronic Activa PC DBS of the Basolateral Nucleus of the Amygdala
    Sponsor:   VA Greater Los Angeles Healthcare System
    Recruiting
  • Adolescent Cancer Telemedicine for Pain Management
    NCT03603886
    Condition:   Cancer
    Interventions:   Behavioral: Telemedicine Pain Management Intervention (immediate group);   Behavioral: Telemedicine Pain Management Intervention (waitlist group, intervention administered following 4-week waitlist period)
    Sponsors:   University of California, Los Angeles;   Rally Foundation for Childhood Cancer Research;   Bear Necessities Pediatric Cancer Foundation
    Recruiting
  • At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
    NCT01931644
    Conditions:   All Diagnosed Health Conditions;   ADD/ADHD;   Alopecia Areata;   Ankylosing Spondylitis;   Asthma;   Atopic Dermatitis Eczema;   Beta Thalassemia;   Bipolar Disorder;   Breast Cancer;   Celiac Disease;   Cervical Cancer;   Chronic Inflammatory Demyelinating Polyneuropathy;   Chronic Kidney Diseases;   Chronic Obstructive Pulmonary Disease;   Colon Cancer;   Colorectal Cancer;   Crohn's Disease;   Cystic Fibrosis;   Depression;   Diabetes Mellitus;   Duchenne Muscular Dystrophy;   Endometriosis;   Epilepsy;   Facioscapulohumeral Muscular Dystrophy;   G6PD Deficiency;   General Anxiety Disorder;   Hepatitis B;   Hereditary Hemorrhagic Telangiectasia;   HIV/AIDS;   Human Papilloma Virus;   Huntington's Disease;   Idiopathic Thrombocytopenic Purpura;   Insomnia;   Kidney Cancer;   Leukemia;   Lung Cancer;   Lupus Nephritis;   Lymphoma;   Melanoma;   Multiple Myeloma;   Multiple Sclerosis;   Myositis;   Myotonic Dystrophy;   Ovarian Cancer;   Pancreatic Cancer;   Parkinson's Disease;   Polycystic Kidney Diseases;   Prostate Cancer;   Psoriasis;   Psoriatic Arthritis;   Rosacea;   Scleroderma;   Sickle Cell Anemia;   Sickle Cell Trait;   Sjogren's Syndrome;   Skin Cancer;   Spinal Muscular Atrophy;   Systemic Lupus Erythematosus;   Thrombotic Thrombocytopenic Purpura;   Trisomy 21;   Ulcerative Colitis
    Intervention:  
    Sponsor:   Sanguine Biosciences
    Recruiting
  • N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization
    NCT03451435
    Condition:   Endodontic Disease
    Intervention:   Drug: N acetyl cysteine
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Light-Scattering Spectroscopy for Detection of Breast Cancer
    NCT01755208
    Conditions:   Healthy, no Evidence of Disease;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
    Intervention:   Procedure: light-scattering spectroscopy
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage
    NCT03065465
    Condition:   Upper Gastrointestinal Hemorrhage
    Interventions:   Device: Over-the-scope hemoclipping device;   Other: Standard endoscopic treatment
    Sponsors:   CURE Digestive Diseases Research Center;   University of California, Los Angeles;   VA Greater Los Angeles Healthcare System
    Recruiting
  • Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer
    NCT03057639
    Condition:   Malignant Neoplasm
    Interventions:   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
    NCT02987725
    Condition:   Sickle Cell Disease
    Interventions:   Behavioral: Hypnosis;   Behavioral: Attention Control
    Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting
  • Acromegaly Combination Treatment Study
    NCT01538966
    Condition:   Acromegaly
    Interventions:   Drug: Pegvisomant;   Drug: Octreotide LAR;   Drug: Lanreotide
    Sponsor:   Cedars-Sinai Medical Center
    Recruiting
  • Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa
    NCT02948452
    Conditions:   Anorexia Nervosa, Restricting Type;   Anxiety
    Intervention:   Other: fMRI
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images
    NCT03694145
    Conditions:   Diabetic Retinopathy;   Diabetic Macular Edema
    Intervention:   Other: In-Person Eye Examination
    Sponsors:   Charles Drew University of Medicine and Science;   National Library of Medicine (NLM);   Los Angeles County Department of Public Health;   University of California, Los Angeles
    Recruiting
  • Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV
    NCT04025463
    Conditions:   HIV/AIDS;   Cardiovascular Risk Factors;   Trauma, Psychological
    Intervention:   Behavioral: HHMB
    Sponsors:   University of California, Los Angeles;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting
  • A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
    NCT04025216
    Conditions:   Non-Small Cell Lung Cancer;   Ovarian Cancer;   Fallopian Tube Cancer;   Triple Negative Breast Cancer;   Multiple Myeloma;   Pancreatic Ductal Adenocarcinoma
    Interventions:   Biological: CART-TnMUC1;   Drug: Cyclophosphamide;   Drug: Fludarabine
    Sponsor:   Tmunity Therapeutics
    Recruiting
  • Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
    NCT03943082
    Condition:   Malignant Neoplasm
    Interventions:   Behavioral: Cancer Educational Materials;   Other: Follow-Up Care;   Behavioral: Questionnaire
    Sponsors:   University of California, San Francisco;   Lazarex Cancer Foundation
    Recruiting
  • Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
    NCT03856034
    Conditions:   Neural Tube Defects;   Spina Bifida;   Myelomeningocele;   Chiari Malformation
    Intervention:   Device: Fetoscopy
    Sponsors:   USFetus;   Wellington Hospital;   University of Southern California
    Recruiting
  • A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
    NCT03646071
    Conditions:   Locally Advanced Solid Tumors;   Metastatic Solid Tumors
    Intervention:   Drug: RX108
    Sponsor:   NeuPharma, Inc.
    Recruiting
  • A Nutrition-Focused QIP in Outpatient Clinics
    NCT03628196
    Condition:   Malnutrition
    Intervention:  
    Sponsors:   Abbott Nutrition;   University of Southern California
    Recruiting
  • Therapeutic Vaccination in Treated HIV Disease
    NCT03606213
    Condition:   HIV-1-infection
    Interventions:   Biological: PENNVAX-GP;   Biological: INO-6145;   Biological: INO-9012;   Device: CELLECTRA® 2000
    Sponsors:   Steven Deeks;   National Institute of Allergy and Infectious Diseases (NIAID);   University of California, Los Angeles;   Inovio Pharmaceuticals
    Recruiting
  • Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
    NCT03564288
    Condition:   Acute Myeloid Leukemia
    Intervention:   Drug: SKI-G-801
    Sponsors:   Oscotec Inc.;   PPD
    Recruiting
  • A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers
    NCT03455569
    Conditions:   Sleep;   Alzheimer Disease
    Interventions:   Behavioral: Behavioral sleep education;   Behavioral: Education only
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Treatment for Affect Dimensions
    NCT03439748
    Conditions:   Anhedonia;   Depression;   Anxiety
    Interventions:   Behavioral: Positive Affect Treatment;   Behavioral: Negative Affect Treatment
    Sponsors:   University of California, Los Angeles;   Southern Methodist University
    Recruiting
  • Deep Brain Stimulation (DBS) for Depression Using Directional Current Steering and Individualized Network Targeting
    NCT03437928
    Condition:   Major Depressive Disorder
    Intervention:   Device: Directional Deep Brain Stimulation
    Sponsors:   Baylor College of Medicine;   University of California, Los Angeles
    Recruiting
  • Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
    NCT02626507
    Condition:   Breast Cancer
    Interventions:   Drug: Gedatolisib;   Drug: Faslodex;   Drug: Palbociclib;   Drug: Zoladex
    Sponsor:   Hoffman Oncology
    Recruiting
  • Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma
    NCT04119024
    Conditions:   Clinical Stage IV Cutaneous Melanoma AJCC v8;   IL13RA2 Positive;   Metastatic Melanoma;   Cutaneous Melanoma, Stage III;   Cutaneous Melanoma, Stage IV
    Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Biological: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells;   Drug: Recombinant Interleukin-2
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation
    NCT03829410
    Conditions:   Metastatic Colorectal Cancer;   KRAS Gene Mutation
    Interventions:   Drug: Onvansertib;   Biological: Bevacizumab;   Drug: FOLFIRI
    Sponsor:   Trovagene, Inc.
    Recruiting
  • Psychosocial Outcomes in Hand Therapy
    NCT03458013
    Condition:   Hand Injuries
    Intervention:   Behavioral: Mindfulness Meditation
    Sponsors:   University of Southern California;   Abbott Medical Devices;   California Foundation for Occupational Therapy
    Recruiting
  • Engaging Seronegative Youth to Optimize HIV Prevention Continuum
    NCT03134833
    Conditions:   HIV;   Mental Health;   Substance Use;   STI
    Interventions:   Behavioral: Automated Messaging & Monitoring;   Behavioral: Peer Support;   Behavioral: Coaching
    Sponsors:   University of California, Los Angeles;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Tulane University Health Sciences Center;   University of California, San Francisco;   Friends Research Institute, Inc.
    Recruiting
  • Stepped Care for Youth Living With HIV
    NCT03109431
    Conditions:   HIV;   Mental Health;   Illicit Substance Use;   Sexually Transmitted Infections (STI)
    Interventions:   Behavioral: Level 1;   Behavioral: Level 2;   Behavioral: Level 3
    Sponsors:   University of California, Los Angeles;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Wake Forest University Health Sciences;   Tulane University Health Sciences Center;   Columbia University
    Recruiting
  • Nicotinamide as an Early Alzheimer's Disease Treatment
    NCT03061474
    Conditions:   Alzheimer's Disease;   Mild Cognitive Impairment
    Interventions:   Drug: Nicotinamide;   Drug: Placebo Comparator
    Sponsor:   University of California, Irvine
    Recruiting
  • Combination Therapy With Pembrolizumab and sEphB4-HSA in Previously Treated Urothelial Carcinoma
    NCT02717156
    Condition:   Stage IV Bladder Urothelial Carcinoma
    Interventions:   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
    NCT03354728
    Conditions:   Cytomegalovirus Positive;   Hematopoietic Cell Transplant Recipient
    Interventions:   Biological: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine;   Other: Laboratory Biomarker Analysis
    Sponsor:   City of Hope Medical Center
    Recruiting
  • Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
    NCT02853097
    Conditions:   Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma
    Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Pembrolizumab in Treating Participants With Leukoplakia
    NCT03603223
    Conditions:   Erythroleukoplakia;   Leukoplakia;   Verrucous Oral Leukoplakia
    Intervention:   Biological: Pembrolizumab
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI);   Merck Sharp & Dohme Corp.
    Recruiting
  • Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
    NCT03330821
    Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Acute Myeloid Leukemia With Myelodysplasia-Related Changes;   Therapy-Related Acute Myeloid Leukemia
    Interventions:   Drug: Cytarabine;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Pevonedistat;   Other: Pharmacological Study
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection
    NCT03205696
    Condition:   Human Immunodeficiency Virus
    Intervention:   Drug: Antiretrovirals
    Sponsors:   University of California, Los Angeles;   Los Angeles LGBT Center;   Tulane University
    Recruiting
  • Optimizing IV Gentamicin in JEB
    NCT04140786
    Condition:   Junctional Epidermolysis Bullosa
    Intervention:   Drug: Gentamicin Sulfate, Injectable
    Sponsor:   University of Southern California
    Recruiting
  • Addressing Obesity in Early Care and Education Settings
    NCT04140032
    Condition:   Obesity
    Intervention:   Behavioral: Multi-level preschool obesity control intervention
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Music Appreciation After Cochlear Implantation
    NCT04099368
    Conditions:   Hearing Loss;   Cochlear Implants
    Intervention:   Behavioral: Musical pitch training
    Sponsors:   University of Southern California;   Ohio State University;   University of California, Merced
    Recruiting
  • Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
    NCT03981926
    Conditions:   Atopic Dermatitis Eczema;   Atopic Dermatitis;   Eczema
    Intervention:   Other: Team-Based Connected Health (TCH)
    Sponsors:   University of Southern California;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    Recruiting
  • N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
    NCT03759678
    Conditions:   Ataxia Telangiectasia;   Louis Bar Syndrome
    Intervention:   Drug: IB1001
    Sponsor:   IntraBio Inc
    Recruiting
  • 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
    NCT03368547
    Conditions:   Prostate Adenocarcinoma;   Stage IIB Prostate Cancer AJCC v7;   Stage III Prostate Cancer AJCC v7;   Stage IV Prostate Cancer AJCC v7
    Interventions:   Procedure: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA-11;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
    NCT03240861
    Conditions:   HLA-A*0201 Positive Cells Present;   Locally Advanced Malignant Neoplasm;   NY-ESO-1 Positive;   Unresectable Malignant Neoplasm;   Sarcoma
    Interventions:   Other: 18F-FHBG;   Biological: Aldesleukin;   Drug: Busulfan;   Biological: Cellular Therapy;   Procedure: Computed Tomography;   Biological: Filgrastim;   Drug: Fludarabine;   Procedure: Leukapheresis;   Drug: Plerixafor;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   California Institute for Regenerative Medicine (CIRM);   National Cancer Institute (NCI)
    Recruiting
  • Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
    NCT02940262
    Conditions:   Prostate Adenocarcinoma;   PSA Progression;   Recurrent Prostate Carcinoma
    Interventions:   Radiation: Gallium Ga 68-labeled PSMA-11;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Biologic Mesh in Preventing Hernia in Patients With Bladder Cancer Undergoing Radical Cystectomy With Ileal Conduit Diversion
    NCT02439060
    Conditions:   Bladder Carcinoma;   Hernia
    Intervention:   Other: Acellular Cadaveric Dermal Matrix
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Musculoskeletal Transplant Foundation
    Recruiting
  • Time Limited Trials to Reduce Non-Beneficial Intensive Care Unit Treatments
    NCT04181294
    Conditions:   Critical Illness;   Communication
    Interventions:   Behavioral: Family meetings using time limited trials as default ICU communication and care planning approach;   Behavioral: Usual practice
    Sponsors:   Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;   Los Angeles Department of Health Services;   University of California, Los Angeles
    Recruiting
  • sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
    NCT04033432
    Conditions:   Castration Levels of Testosterone;   Castration-Resistant Prostate Carcinoma;   Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents;   Metastatic Prostate Adenocarcinoma;   Progressive Disease;   Prostate Carcinoma Metastatic in the Bone;   Prostate Carcinoma Metastatic in the Soft Tissue;   PSA Progression;   Stage IVB Prostate Cancer AJCC v8;   Testosterone Less Than 50 ng/dL
    Intervention:   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   Northwestern University;   Vasgene Therapeutics, Inc;   National Cancer Institute (NCI)
    Recruiting
  • Early Feasibility Study for the Foldax Tria Aortic Heart Valve
    NCT03851068
    Conditions:   Aortic Valve Disease;   Aortic Valve Stenosis
    Intervention:   Device: Foldax Tria Aortic Valve
    Sponsor:   Foldax, Inc
    Recruiting
  • Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
    NCT03732950
    Conditions:   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
    Intervention:   Biological: Pembrolizumab
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting
  • Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
    NCT03657641
    Conditions:   Colorectal Cancer;   Colorectal Cancer Metastatic
    Interventions:   Biological: Pembrolizumab;   Drug: Regorafenib
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting
  • Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
    NCT03383419
    Condition:   Heart Failure
    Intervention:   Drug: Epclusa
    Sponsor:   Baylor Research Institute
    Recruiting
  • Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
    NCT03317405
    Conditions:   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Stage 0 Breast Cancer AJCC v6 and v7;   Stage I Breast Cancer AJCC v7;   Stage IA Breast Cancer AJCC v7;   Stage IB Breast Cancer AJCC v7;   Stage II Breast Cancer AJCC v6 and v7;   Stage IIA Breast Cancer AJCC v6 and v7;   Stage IIB Breast Cancer AJCC v6 and v7;   Stage III Breast Cancer AJCC v7;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7
    Interventions:   Other: Placebo Administration;   Other: Questionnaire Administration;   Drug: Z-Endoxifen Hydrochloride
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Maraviroc to Augment Rehabilitation Outcomes After Stroke
    NCT03172026
    Condition:   Stroke
    Interventions:   Drug: Maraviroc 300 mg;   Behavioral: Rehabilitation therapy;   Drug: Placebo 300 mg
    Sponsors:   University of California, Los Angeles;   Burke Neurological Research Institute;   Yale University
    Recruiting
  • Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
    NCT02985021
    Conditions:   Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
    Interventions:   Drug: Carboplatin;   Drug: Docetaxel
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   Prostate Cancer Foundation;   VA Puget Sound Health Care System
    Recruiting
  • Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
    NCT02635061
    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: ACY-241;   Drug: Nivolumab
    Sponsor:   Celgene
    Recruiting
  • Rizatriptan for Episodic Dizziness in Vestibular Migraine
    NCT02447991
    Conditions:   Vestibular Migraine;   Migrainous Vertigo
    Interventions:   Drug: Rizatriptan;   Drug: Placebo
    Sponsor:   Robert W. Baloh
    Recruiting
  • Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib
    NCT03935555
    Conditions:   Primary Myelofibrosis (PMF);   Post-Polycythemia Vera Myelofibrosis (Post-PV MF);   Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
    Intervention:   Drug: PU-H71
    Sponsor:   Samus Therapeutics, Inc.
    Recruiting
  • Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or Lymphoma
    NCT03775525
    Conditions:   Advanced Cancer;   Gastric Cancer;   Breast Cancer;   Pancreatic Cancer;   Prostate Cancer Metastatic;   Colo-rectal Cancer;   Solid Tumor;   Solid Carcinoma;   Solid Carcinoma of Stomach;   Cancer of Stomach;   Lymphoma;   Sarcoma;   Cutaneous T Cell Lymphoma;   Head and Neck Squamous Cell Carcinoma;   Basal Cell Carcinoma;   Cutaneous T-cell Lymphoma;   Cutaneous Squamous Cell Carcinoma
    Intervention:   Drug: GZ17-6.02
    Sponsors:   Genzada Pharmaceuticals USA, Inc.;   Translational Drug Development
    Recruiting
  • The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
    NCT03640325
    Conditions:   Cancer;   Bone Marrow Neoplasms;   Anxiety;   Depression;   Quality of Life;   Adherence, Medication;   Coping Skills;   Adolescent Behavior
    Intervention:   Behavioral: PRISM (Promoting Resilience in Stress Management)
    Sponsors:   Seattle Children's Hospital;   Children's Hospital Los Angeles;   St. Jude Children's Research Hospital
    Recruiting
  • Brain Implant for Neural Control of a Computer
    NCT01958086
    Condition:   Quadriplegia
    Intervention:   Device: Neural Communication System
    Sponsors:   Richard A. Andersen, PhD;   University of California, Los Angeles;   Casa Colina Hospital and Centers for Healthcare
    Recruiting
  • Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
    NCT03518203
    Conditions:   Thrombotic Microangiopathies;   Atypical Hemolytic Uremic Syndrome;   Multiple Organ Dysfunction Syndrome
    Intervention:   Drug: Eculizumab
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting
  • Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
    NCT03041701
    Conditions:   Rhabdomyosarcoma;   Rhabdomyosarcoma- Alveolar;   Rhabdomyosarcoma-Embryonal
    Interventions:   Drug: Dasatinib;   Drug: Ganitumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
    NCT02875353
    Condition:   Delayed Post-Polypectomy Induced Ulcer Hemorrhage
    Intervention:   Device: Doppler Endoscopic Probe
    Sponsors:   VA Office of Research and Development;   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting
  • Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
    NCT02502786
    Condition:   Recurrent Osteosarcoma
    Interventions:   Biological: humanized anti-GD2 antibody;   Drug: GM-CSF
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Children's Hospital Los Angeles;   M.D. Anderson Cancer Center;   Y-mAbs Therapeutics
    Recruiting
  • A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia
    NCT02028455
    Condition:   CD19+ Acute Leukemia
    Intervention:   Biological: Patient Derived CD19 specific CAR T cells also expressing an EGFRt
    Sponsor:   Seattle Children's Hospital
    Recruiting
  • Providing Closed Loop Cortical Control of Extracorporeal Devices to Patients With Quadriplegia
    NCT01964261
    Condition:   Quadriplegia
    Intervention:   Device: Neural Prosthetic System 2 (NPS2)
    Sponsors:   Richard A. Andersen, PhD;   University of Southern California;   Rancho Los Amigos National Rehabilitation Center
    Recruiting
  • Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
    NCT01466114
    Conditions:   Relapsing-remitting Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis;   Primary-progressive Multiple Sclerosis
    Interventions:   Drug: estriol;   Other: Placebo;   Drug: Norethindrone;   Other: Progestin Placebo
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Registry Study of Revcovi Treatment in Patients With ADA-SCID
    NCT03878069
    Conditions:   Adenosine Deaminase Deficiency;   Severe Combined Immunodeficiency
    Intervention:   Biological: elapegademase-lvlr
    Sponsor:   Leadiant Biosciences, Inc.
    Recruiting
  • Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
    NCT03568669
    Conditions:   Congenital Central Hypoventilation Syndrome;   Congenital Central Hypoventilation;   CCHS;   CCHS With Hirschsprung Disease;   CCHS With Neural Crest Tumor;   CCHS With Neuroblastoma
    Intervention:   Other: NIH Toolbox Cognition Battery
    Sponsors:   Debra Weese-Mayer;   Ann & Robert H Lurie Children's Hospital of Chicago;   Seattle Children's Hospital;   Children's Hospital Los Angeles
    Recruiting
  • Study to Evaluate the Safety and Efficacy of GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIV
    NCT04143594
    Condition:   HIV-1-infection
    Interventions:   Drug: Oral GS-6207;   Drug: F/TAF;   Drug: Subcutaneous GS-6207;   Drug: TAF;   Drug: BIC;   Drug: B/F/TAF
    Sponsor:   Gilead Sciences
    Recruiting
  • A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
    NCT03652077
    Conditions:   Cervical Cancer;   Gastric Cancer;   Stomach Cancer;   Gastroesophageal Junction Cancer;   Esophageal Cancer;   Hepatocellular Carcinoma;   Melanoma;   Uveal Melanoma;   Merkel Cell Carcinoma;   Mesothelioma;   MSI;   Non-small Cell Lung Cancer;   NSCLC;   Ovarian Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Small Cell Lung Cancer;   Renal Cell Carcinoma;   RCC;   Triple-negative Breast Cancer;   Urothelial Carcinoma;   Mismatch Repair Deficiency
    Intervention:   Drug: INCAGN02390
    Sponsor:   Incyte Corporation
    Recruiting
  • A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
    NCT03538028
    Conditions:   Cervical Cancer;   Microsatellite Instability (MSI)-High Endometrial Cancer;   Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]);   Esophageal Cancer;   Hepatocellular Carcinoma;   Melanoma (Uveal Melanoma Excluded);   Merkel Cell Carcinoma;   Mesothelioma;   MSI-high Colorectal Cancer;   Non-small Cell Lung Cancer (NSCLC);   Ovarian Cancer;   Squamous Cell Carcinoma of the Head and Neck (SCCHN);   Small Cell Lung Cancer (SCLC);   Renal Cell Carcinoma (RCC);   Triple-negative Breast Cancer;   Urothelial Carcinoma;   Diffuse Large B-cell Lymphoma
    Intervention:   Biological: INCAGN02385
    Sponsor:   Incyte Biosciences International Sàrl
    Recruiting
  • Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma
    NCT03084640
    Condition:   Malignant Melanoma
    Interventions:   Drug: CMP-001;   Drug: Pembrolizumab
    Sponsor:   Checkmate Pharmaceuticals
    Recruiting
  • Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
    NCT03077685
    Condition:   Locally Advanced Pancreatic Adenocarcinoma
    Intervention:   Drug: NanoPac®
    Sponsors:   NanOlogy, LLC;   US Biotest, Inc.
    Recruiting
  • Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial
    NCT03052920
    Condition:   Hearing Loss
    Intervention:   Device: Cochlear implant
    Sponsors:   Washington University School of Medicine;   Midwest Ear Institute;   House Clinic, Inc.;   NYU Langone Health
    Recruiting
  • Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
    NCT03016741
    Conditions:   Castration-Resistant Prostatic Cancer;   Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer;   Hormone-Refractory Prostate Cancer
    Interventions:   Biological: GnRH agonist/antagonist;   Drug: Prednisone;   Drug: Abiraterone Acetate;   Drug: Enzalutamide
    Sponsor:   Northwestern University
    Recruiting
  • Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
    NCT02968810
    Condition:   Cirrhosis
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo Administration;   Other: Questionnaire Administration;   Drug: Simvastatin
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
    NCT02935361
    Conditions:   Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    Interventions:   Drug: Atezolizumab;   Drug: Guadecitabine
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Van Andel Research Institute
    Recruiting
  • High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
    NCT03178617
    Conditions:   Caregiver;   Childhood Acute Lymphoblastic Leukemia;   Childhood Acute Myeloid Leukemia;   Childhood Lymphoblastic Lymphoma;   Acute Leukemia;   Parent
    Interventions:   Other: Educational Intervention;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting
  • Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma
    NCT02619253
    Conditions:   Renal Cell Carcinoma;   Urinary Bladder Neoplasms
    Interventions:   Drug: Pembrolizumab;   Drug: Vorinostat
    Sponsor:   Roberto Pili
    Recruiting
  • The Use of PRP and BMC in Patients With Internal Disc Disruption Multicenter Prospective Randomized Controlled Trial in Patients With Internal Disc Disruption
    NCT04102761
    Condition:   Internal Disc Disruption
    Intervention:   Procedure: Intradiscal PRP & BMC Injections
    Sponsors:   Annu Navani, MD;   Andrews Research & Education Foundation
    Recruiting
  • The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer
    NCT03668223
    Conditions:   Cancer;   Quality of Life;   Anxiety;   Depression;   Hope;   Coping Skills;   Communication
    Intervention:   Behavioral: Promoting Resilience in Stress Management (PRISM)
    Sponsors:   Seattle Children's Hospital;   Children's Hospital Los Angeles;   Texas Children's Hospital
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC